SymBio Pharmaceuticals Limited

TSE:4582.T

172 (JPY) • At close March 13, 2025
Overview | Financials

Numbers are in millions (except for per share data and ratios) JPY.

2024 Q42024 Q32024 Q22024 Q12023 Q42023 Q32023 Q22023 Q12022 Q42022 Q32022 Q22022 Q12021 Q42021 Q32021 Q22021 Q12020 Q42020 Q32020 Q22020 Q12019 Q42019 Q32019 Q22019 Q12018 Q42018 Q32018 Q22018 Q12017 Q42017 Q32017 Q22017 Q12016 Q42016 Q32016 Q22016 Q12015 Q42015 Q32015 Q22015 Q12014 Q42014 Q32014 Q22014 Q12013 Q42013 Q32013 Q22013 Q12012 Q42012 Q32011 Q42011 Q32011 Q22011 Q1
Operating Activities:
Net Income -988.456-1,303.683-763.944-777-1,174-709-834-3764479451631,707.348530.4154.099-209.659-1,395.932-809.308-892.806-992.17-735.702-1,570.627-1,452.97-616.959-811.691-552.34-628.81-759.692-431.84-2,279.676-683.578-582.768-397.437-740.458-522.707-652.631-1,572.67-383.001-255.928-420.496-172.225-228.297-260.5-454.855-414.467-376.626-460.756-353.375-473.673-361.959-328.415-1,066.858-307.314-398.126
Depreciation & Amortization 000023.83423.78223.85524.53423.85725.85500000000000000000000000000000000000000002.1252.1012.1381.803
Deferred Income Tax 000000000000000000000000000000000000000000000000000000
Stock Based Compensation 93.409-50.21350.213000000000124.27-58.19458.1940102.378-55.10655.1060127.144-73.78773.7870122.944-64.63664.6360121.205-67.1267.120137.01-65.03965.0390102.898-49.07649.076094.731-41.76541.765066.534-27.93827.938027.167-7.3270000
Change In Working Capital 0000000000000000000000000000000000000000000000000042.09369.412-199.9550.567
Accounts Receivables 000000000000000000000000000000000000000000000000000000
Change In Inventory 00000000000000000000000000000000000000000000000000-111.689140.398-115.209-120.967
Change In Accounts Payables 000000000000000000000000000000000000000000000000000000
Other Working Capital 00000000000000000000000000000000000000000000000000153.782-70.986-84.741171.534
Other Non Cash Items 895.0471,353.896713.7317771,17470983-4376-447-945-163-1,831.618-472.221-62.293209.6591,293.554864.414837.7992.17608.5581,644.4141,379.183616.959688.747616.976564.174759.692310.6352,346.796616.458582.768260.427805.497457.668652.6311,469.772432.077206.852420.49677.494270.062218.735454.855347.933404.564432.818353.375473.673361.9598.01421.8269.82616.701
Operating Cash Flow 000047.66847.56447.7149.06847.71451.710000000000000000000000000000000000000000-276.183-973.519-495.3-329.055
Investing Activities:
Investments In Property Plant And Equipment 00000000000000000000000000000000000000000000000000-0.255000
Acquisitions Net 000000000000000000000000000000000000000000000000000000
Purchases Of Investments 00000000000000000000000000000000000000000000000000-100.673000
Sales Maturities Of Investments 00000000000000000000000000000000000000000000000000000100
Other Investing Activites 000000000000000000000000000000000000000000000000000-3.329-113.1490.05
Investing Cash Flow 00000000000000000000000000000000000000000000000000-100.928-3.329-113.149100.05
Financing Activities:
Debt Repayment 000000000000000000000000000000000000000000000000000000
Common Stock Issued 000000000000000000000000000000000000000000000000002,627.52012.041,988
Common Stock Repurchased 00000000000000000000000000000000000000000000000000-9.7380-0.042-6.958
Dividends Paid 000000000000000000000000000000000000000000000000000000
Other Financing Activities 00000000000000000000000000000000000000000000000000-0.001-250249.9990
Financing Cash Flow 000000000000000000000000000000000000000000000000002,617.781-250261.9971,981.042
Other Information:
Effect Of Forex Changes On Cash 00000000000000000000000000000000000000000000000000-3.36-17.375-3.490.032
Net Change In Cash 0000402.1438.841136.456-342.984149.477327.26700000000000000000000000000000000000000002,237.31-1,244.223-349.9431,752.069
Cash At End Of Period 00006,517.0076,114.8676,076.0265,939.576,282.5546,133.07700000000000000000000000000000000000000006,310.9784,073.6685,317.8915,667.834